Logo
DeutschClear Cookie - decide language by browser settings
Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Jump to: 2002 | 1992 | 1988 | 1986
Number of items: 5.

2002

Classen, S.; Kopp, R.; Possinger, K.; Weidenhagen, R.; Eiermann, W.; Wilmanns, W. (2002): Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy. In: Tumor Biology, No. 2: pp. 70-75 [PDF, 83kB]

1992

Schleuning, M.; Schmid-Haslbeck, M.; Utz, H.; Jochum, Marianne; Heim, M.; Mempel, W.; Wilmanns, W. (June 1992): Complement activation during storage of blood under normal blood bank conditions. Effects of proteinase inhibitors and of leukocyte depletion. In: Blood, Vol. 79, No. 11: pp. 3071-3075 [PDF, 1MB]

1988

Gerbes, Alexander L.; Mezger, J.; Permanetter, W.; Wilmanns, W.; Lamerz, Rolf (1988): Tumor associated antigens in diagnosis of serous effusions. In: Journal of clinical pathology, Vol. 41: pp. 633-643 [PDF, 2MB]

1986

Mezger, J.; Lamerz, Rolf; Gerbes, Alexander L.; Arnholdt, H.; Wilmanns, W. (1986): Unterscheidung benigner und maligner Ursachen von Aszites und Pleuraergüssen mit der Hilfe von Tumormarkern. Hamburger Symposium über Tumormarker, 1985, Hamburg. [PDF, 2MB]

Gilg, T.; Klaubert, W.; Schönbauer, R.; Gollwitzer, R.; Kauert, G.; Eisenmenger, Wolfgang; Wilmanns, W. (1986): Untersuchungen über postmortal im Blut abgelaufene, koagulatorische und fibrinolytische Reaktionsmechanismen. In: Beiträge zur gerichtlichen Medizin, Vol. 44: pp. 399-405 [PDF, 2MB]

This list was generated on Mon Aug 29 02:11:20 2016 CEST.